Travelers Companies (The) (TRV)

Cost of Revenue

$31.87B

TTM · Period ending: · USD

TRV logo

TRV Cost of Revenue

Latest reported$31.87B
TRV TTM Cost of Revenue ($0.00 → $31.87B)
High-resolution chart · PNG

TRV cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Travelers Companies (The) Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
31,868,000,000
31,968,000,000
32,851,000,000
34,487,000,000
34,659,000,000
35,002,000,000
35,462,000,000
34,032,000,000
33,712,000,000
33,679,000,000
33,374,000,000
32,441,000,000
32,278,000,000
31,019,000,000
29,441,000,000
28,369,000,000
27,131,000,000
26,382,000,000
25,513,000,000
25,341,000,000
24,777,000,000
24,125,000,000
24,106,000,000
23,896,000,000
24,161,000,000
24,467,000,000
24,142,000,000
23,734,000,000
23,813,000,000
23,186,000,000
22,874,000,000
22,672,000,000
22,186,000,000
22,279,000,000
21,893,000,000
21,633,000,000
20,972,000,000
19,975,000,000
19,469,000,000
19,055,000,000
18,637,000,000
18,138,000,000
17,897,000,000
17,608,000,000
17,465,000,000
17,600,000,000
17,881,000,000
17,752,000,000
17,857,000,000
17,603,000,000
17,292,000,000
17,128,000,000
17,975,000,000
18,070,000,000
18,352,000,000
18,586,000,000
18,035,000,000
18,808,000,000
20,157,000,000
20,152,000,000
19,706,000,000
18,767,000,000
17,025,000,000
17,012,000,000
16,574,000,000
16,485,000,000
16,404,000,000
16,221,000,000
12,512,000,000
13,283,000,000
13,048,000,000
12,889,000,000
16,982,000,000
16,062,000,000
16,020,000,000
16,103,000,000
15,879,000,000
15,843,000,000
15,799,000,000
15,583,000,000
16,785,000,000
18,071,000,000
17,988,000,000
18,179,000,000
18,138,000,000
17,853,000,000
19,643,000,000
18,417,000,000
15,418,000,000
13,261,000,000
10,282,000,000
10,225,600,000
9,690,600,000
8,819,600,000
8,551,600,000
7,627,000,000
9,082,000,000
10,056,000,000
9,331,000,000
9,068,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.